Laura Roca-Alonso, PhD
Chief Operating and Business Officer
Laura is the COO/CBO of Tangram Therapeutics. She drives the company’s relentless progress and growth with a focus on strategy and execution. Dr. Roca-Alonso oversees business operations and corporate functions, working to realize our mission of bringing transformative medicines patients to patients by uniting AI and RNAi.
Laura brings strategic experience in the discovery and development of genetic medicines, as well as in building biotechnology companies at different R&D stages, from platform development to clinic. Prior to Tangram, she worked at Gyroscope Therapeutics (a retinal gene therapy company acquired by Novartis) and Silence Therapeutics, a NASDAQ listed RNAi company. Laura earned her PhD from Imperial College London, an MRes in Biomedicine from University College London (UCL), and a BSc in Biotechnology from Universitat Autònoma de Barcelona (UAB).
